Top Stock Reports For Walmart, Pfizer & Charter Communications

By Zacks Investment ResearchStock MarketsMar 05, 2020 02:56AM ET

www.investing.com/analysis/top-stock-reports-for-walmart-pfizer--charter-communications-200513831

Top Stock Reports For Walmart, Pfizer & Charter Communications

By Zacks Investment Research | Mar 05, 2020 02:56AM ET

Saved. See Saved Items.

This article has already been saved in your Saved Items

Thursday, March 5, 2020

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Walmart (NYSE:WMT) (WMT), Pfizer (PFE) and Charter Communications (NASDAQ:CHTR) (CHTR). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Walmart’s shares have underperformed the Zacks Supermarkets industry over the past six months (+1.8% vs. +2.6%). The Zacks analyst believes that the company’s focus on strengthening e-commerce and store operations has helped it retain its sturdy comps trend in fourth-quarter fiscal 2019, wherein U.S. comps rose for the 22nd straight time.

Further, e-commerce sales surged on robust online grocery performance. Management expects e-commerce sales to rise nearly 30% in fiscal 2021, wherein International sales are likely to grow 4%.

However, Walmart’s earnings broke its positive surprise trend and fell year over year in the quarter due to higher cost of sales and increased operating, selling, general and administrative expenses. Additionally, disruption in Chile and a legal matter affected the bottom line. Further, the gross margin remained soft due to pricing and growing e-commerce mix.

(You can read the full research report on Walmart here >>>)

Shares of Pfizer have lost -13.1% over the past year against the Zacks Large-Cap Pharmaceuticals industry’s rise of +5.5%. The Zacks analyst believes that the Consumer Healthcare joint venture with Glaxo, the Array acquisition and the pending merger of Upjohn unit with Mylan (NASDAQ:MYL), if successful, will make Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.

The smaller Pfizer should see better revenue growth as the Lyrica LOE cliff will go away. Pfizer expects continued strong growth of key brands like Ibrance, Inlyta and Eliquis to drive sales in 2020. Pfizer also has a strong portfolio of new drugs, which will accelerate growth in 2020 and beyond. However, Lyrica generic erosion, currency headwinds and pricing pressure are the key near-term top-line headwinds.

(You can read the full research report on Pfizer here >>>)

Charter Communications’ shares have gained +11.7% over the past three months against the Zacks Cable TV industry’s rise of +0.6%. The Zacks analyst believes that the company is benefiting from growth in Internet, mobile, commercial and video revenues.

Increase in Internet speed at no extra cost is also aiding subscriber growth. Additionally, Charter’s spectrum mobile products are gaining traction and subscriber base is increasing rapidly. Launch of spectrum mobile services to small and medium business customers is a key catalyst. Improving free cash flow is a growth driver.

However, commercial revenues continued to suffer due to migration of customers to Spectrum pricing, and packaging from Legacy TWC and Legacy Bright House. Further, Charter persistently loses video subscribers, primarily due to cord-cutting and intense competition from streaming service providers like Netflix (NASDAQ:NFLX) and Amazon (NASDAQ:AMZN).

(You can read the full research report on Charter Communications here >>>)

Other noteworthy reports we are featuring today include Eli Lilly (LLY), Lockheed Martin (LMT) and CME Group (CME).

Free: Zacks’ Single Best Stock Set to Double

Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.

This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.

See 5 Stocks Set to Double>>

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

Walmart's (WMT) Superb U.S. Comps Trend to Fuel Top-Line

Ibrance & Other Key Drugs to Drive Pfizer's (PFE) Sales

Subscriber Gain Aids Charter (CHTR) Amid Stiff Competition

Featured Reports

Lilly (LLY) Makes Solid Pipeline Progress

The Zacks analyst points out that several late-stage data readouts are scheduled for 2020 for Lilly. It is also regularly adding promising new pipeline assets.

Robust Demand Aids Lockheed (LMT), F-35 program's Cost Hurts

Per the Zacks Analyst, Lockheed Martin witnesses strong demand for its aircraft programs and missile defense systems.

CME Group (CME) Futures Expansion Aids, Expenses Hurt

Per the Zacks analyst, the company is well poised for growth with the expansion of futures products in emerging markets and OTC offerings.

Intuit (NASDAQ:INTU) Rides on Solid Product Portfolio & Cloud Shift

Per the Zacks analyst, Intuit is gaining from solid adoption of TurboTax Live offering, and its lending product - QuickBooks Capital.

Intercontinental (ICE (NYSE:ICE)) Gains From Buyouts, Debt High

Per the Zacks analyst, Intercontinental Exchange is set to grow on a number of buyouts and cost synergies.

Kimberly-Clark's (NYSE:KMB) Restructuring Plans to Aid Earnings

Kimberly-Clark expects cost savings of $425-$500 million in 2020, from its FORCE Program and 2018 Global Restructuring Program.

Robust Product Portfolio & Acquisitions Aid ANSYS (ANSS)

Per the Zacks analyst, buyouts like Livermore Software Technology (LSTC) and Dynardo are enabling ANSYS to bring innovative solutions to the market & fortify foothold in the simulations market.

New Upgrades

Label Expansions of Eylea, Dupixent Boost Regeneron (REGN)

Per the Zacks analyst, label expansions of key drugs like Eylea and Dupixent boost Regeneron. The company's efforts to expand the label of these drugs and develop its pipeline are impressive too.

Robust Comparable Store Sales to Aid Cracker Barrel (CBRL)

Per the Zacks analyst, Cracker Barrel continues to benefit from robust comparable store restaurant sales, enhanced marketing efforts, seasonal promotions as well as unit expansions.

Fuel Distribution & Terminalling Businesses Aid Sunoco (SUN)

Per the Zacks analyst, Sunoco's fuel distribution and terminalling businesses are expected to bring higher profits on the back of higher demand in the domestic market.

New Downgrades

Weak Refining & Chemical Businesses Hurt Sinopec (SNP)

Declining demand for petroleum products continues to hurt Sinopec's refining business. Lower contributions from the firm's chemicals operations also concern the Zacks analyst.

VMware (VMW) Hurt By a Rise in Investment on SaaS Portfolio

Per the Zacks analyst, heavy spending on hybrid cloud and SaaS portfolios amid intensifying competition hurts VMware's profitability.

Sluggish Weibo & Portal Advertising Revenues Hurt SINA (SINA)

Per the Zacks Analyst, declining Weibo & portal advertising revenues is hurting SINA's top-line growth. Moreover, intensifying competition is a concern.

undefined undefined

Walmart Inc. (WMT): Free Stock Analysis Report

Pfizer Inc. (NYSE:PFE): Free Stock Analysis Report

Lockheed Martin Corporation (NYSE:LMT): Free Stock Analysis Report

Eli Lilly and Company (NYSE:LLY): Free Stock Analysis Report

CME Group Inc. (NASDAQ:CME): Free Stock Analysis Report

Charter Communications, Inc. (CHTR): Free Stock Analysis Report

Original post

Zacks Investment Research

Lattice Semi: Investors Who Missed This Sell Signal Are Now Counting a... By Chinmay Pandya - Mar 07, 2025

US stocks look expensive by historical standards. As of late January 2025, the S&P 500’s trailing 12-month P/E ratio was at 30.5—well above its 10-year average of 23. This...

Raytheon vs. Lockheed Martin: Which Stock Has More Upside? By Jea Yu - Mar 06, 2025

Defense stocks took a tumble heading into 2025 as President Trump returned to the White House for his second term. Trump has stated his intent as a peacemaker to bring the wars in...

Is the Nasdaq 100 in a Long-Term Bear Market? By Dr. Arnout ter Schure - Mar 06, 2025 5

Using the Elliott Wave Principle (EWP), we have been tracking the most likely path forward for the Nasdaq 100 (NDX). Although there are many ways to navigate the markets and to...

Add a Comment

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

Write your thoughts here

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

Central Banks

Interest Rates

Next Meeting

FED

4.50%

Mar 19, 2025

ECB

2.65%

Apr 17, 2025

BOE

4.50%

Mar 20, 2025

SNB

0.50%

Mar 20, 2025

RBA

4.10%

Apr 01, 2025

BOC

3.00%

Mar 12, 2025

RBNZ

3.75%

Apr 09, 2025

BOJ

0.50%

Mar 19, 2025

CBR

21.00%

Mar 21, 2025

RBI

6.25%

Mar 10, 2025

PBOC

3.10%

BCB

13.25%

Mar 19, 2025

US 30	42,647.5	+68.7	+0.16%
US 500	5,753.6	+15.1	+0.26%
Dow Jones	42,579.08	-427.51	-0.99%
S&P 500	5,738.52	-104.11	-1.78%
Nasdaq	18,069.26	-483.48	-2.61%
S&P 500 VIX	24.87	+2.94	+13.41%
Dollar Index	103.840	-0.188	-0.18%

Crude Oil WTI	66.88	+0.52	+0.78%
Brent Oil	70.00	+0.54	+0.78%
Natural Gas	4.236	-0.066	-1.53%
Gold	2,924.69	-1.91	-0.07%
Silver	33.218	-0.120	-0.36%
Copper	4.7840	-0.0235	-0.49%
US Soybeans	1,024.88	-1.13	-0.11%

U.S. 10Y	4.260	-0.022	-0.51%
U.S. 30Y	4.564	-0.015	-0.33%
U.S. 5Y	4.042	-0.016	-0.39%
U.S. 3M	4.318	+0.006	+0.14%
US 10Y T-Note	111.03	+0.25	+0.23%
Euro Bund	127.66	-0.14	-0.11%
10-2 Yield Spread	27.17	+1.56	+6.09%

Apple	235.33	-0.41	-0.17%
NVIDIA	110.57	-6.73	-5.74%
Alphabet A	172.35	-0.67	-0.39%
Tesla	263.45	-15.65	-5.61%
Amazon.com	200.70	-7.66	-3.68%
Netflix	906.36	-84.56	-8.53%
Meta Platforms	627.93	-28.54	-4.35%

Top Stock Reports For Walmart, Pfizer & Charter Communications

Today's Must Read

Featured Reports

New Upgrades

New Downgrades

Related Articles